Intrinsic Value of S&P & Nasdaq Contact Us

KORU Medical Systems, Inc. KRMD NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
62/100
4/7 Pass
SharesGrow Intrinsic Value
$12.49
+190.5%
Analyst Price Target
$7.00
+62.8%

KORU Medical Systems, Inc. (KRMD) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is bullish — 4 Buy, 1 Hold.

The consensus price target is $7.00 (low: $6.00, high: $8.00), representing an upside of 62.8% from the current price $4.30.

Analysts estimate Earnings Per Share (EPS) of $-0.11 and revenue of $0.03B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.13 vs est $-0.11 (missed -22.6%). 2025: actual $-0.06 vs est $-0.07 (beat +13.5%). Analyst accuracy: 83%.

KRMD Stock — 12-Month Price Forecast

$7.00
▲ +62.79% Upside
Average Price Target
Based on 5 Wall Street analysts offering 12-month price targets for KORU Medical Systems, Inc., the average price target is $7.00, with a high forecast of $8.00, and a low forecast of $6.00.
The average price target represents a +62.79% change from the last price of $4.30.
Highest Price Target
$8.00
Average Price Target
$7.00
Lowest Price Target
$6.00

KRMD Analyst Ratings

Buy
5
Ratings
4 Buy
1 Hold
Based on 5 analysts giving stock ratings to KORU Medical Systems, Inc. in the past 3 months
Rating breakdown
Buy
4 80%
Hold
1 20%
80%
Buy
4 analysts
20%
Hold
1 analysts
0%
Sell
0 analysts

EPS Estimates — KRMD

83%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$0.13 vs Est –$0.11 ▼ 18.5% off
2025 Actual –$0.06 vs Est –$0.07 ▲ 15.6% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — KRMD

100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.034B vs Est $0.034B ▼ 0.1% off
2025 Actual $0.041B vs Est $0.041B ▲ 0.2% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message